Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-04

Clinical Trial Update: A Post-market Registry to Assess Safety and Performance of RefluxStop™ in the Treatment of GERD in General Hospital Practice [NA]

View source ↗

Summary

A post-market registry is planned to assess the safety and performance of RefluxStop for gastroesophageal reflux disease in general hospital practice; recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RefluxStop

Snippet

Sponsor: Implantica CE Reflux Ltd. | Conditions: Gastroesophageal Reflux Disease | NA | Status: NOT_YET_RECRUITING